Pxr modulates the prostate cancer cell response to afatinib by regulating the expression of the monocarboxylate transporter slc16a1

HIGHLIGHTS

• who: Alice Matheux et al. from the Laboratoire de Biochimie et Biologie Moléculaire, CHU Carémeau, Nîmes, France have published the article: PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1, in the Journal: (JOURNAL)
• what: The authors show that the detection of PXR in tumor tissues of PCa patients is correlated with advanced forms of the disease. The authors show that stable expression of PXR altered prostate cancer cell response to a specific subset of kinase inhibitors.
• how: To screen for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.